Literature DB >> 8885996

Endothelin-1 induces insulin resistance in conscious rats.

C C Juan1, V S Fang, Y J Huang, C F Kwok, Y P Hsu, L T Ho.   

Abstract

Since endothelin-1 (ET-1) might regulate insulin secretion and glucose metabolism, we carried out experiments to study the effect of ET-1 in conscious rats by injecting ET-1 (0.5 or 1.0 microgram/100 g body weight, i.p.) and examining the plasma glucose (PG) and insulin (PI) concentrations and PG/PI ratios continuously for 3 hours after the injection. Compared to the saline controls, ET-1 increased PG and PG/ P1 ratios in a dose-dependent manner. Oral glucose tolerance test (OGTT) performed at 30 min after the injection showed that PG levels stayed significantly higher in rats preinjected with ET-1 than rats with saline injection, although the change in PI levels was not different. Simultaneous infusion of glucose and insulin to somatostatin-primed rats with ET-1 or saline injection resulted in significantly higher steady state plasma glucose (SSPG) levels and SSPG/PI ratios in rats injected with ET-1 than control rats with saline. These results unequivocally indicated that intraperitoneally administered ET-1 induces insulin resistance in conscious rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885996     DOI: 10.1006/bbrc.1996.1571

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

Review 2.  Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress.

Authors:  Balasubramaniyan Vairappan
Journal:  World J Hepatol       Date:  2015-03-27

3.  Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism.

Authors:  Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

4.  Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.

Authors:  K I Ishibashi ; T Imamura; P M Sharma; J Huang; S Ugi; J M Olefsky
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

5.  Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study.

Authors:  Low-Tone Ho; Yung-Pei Hsu; Chin-Fu Hsiao; Chih-Tai Ting; Kuang-Chung Shih; Lee-Ming Chuang; Kamal Masaki; John Grove; Thomas Quertermous; Chi-Chung Juan; Ming-Wei Lin; Shu-Chiung Chiang; Yii-Der I Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.